Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01091805 · ClinicalTrials.gov registry record

Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux

A clinical trial, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
143
Enrollment target

NCT01091805 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 143 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01091805 has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
143 participants
Enrollment target

Study Summary

The purpose of this research study is to see if GE reflux events are associated with increasing levels of pepsin in spit samples. Pepsin is a special protein called an "enzyme" that is made only in your stomach. It is not normally found in your throat. Pepsin breaks down food proteins that you eat to form nutritional building blocks that your body can use to grow. An enzyme is a substance that helps break down proteins. Gastroesophageal reflux disease (GERD) is very common in infants and children, but can result in serious health problems if not accurately diagnosed. The investigators currently do not have a definitive test to be used as a standard for diagnosing pediatric GERD. Measurement of pepsin, an enzyme normally produced only in the stomach, has been used as a non-invasive way to detect gastric aspiration (reflux of stomach fluid into the airway) in both adults and children, but using pepsin to detect reflux has not been tested. Since pepsin should not be present in the normal esophagus and respiratory tract, but is always present in reflux fluid from the stomach, the investigators believe that the more GE reflux the investigators detect, the higher the levels of pepsin the investigators see in the fluid collected from the mouth. If patients do not have GE reflux, but have swallowing problems alone in which food or liquid goes into the airway, the investigators expect that these patients will have no pepsin in the fluid collected from their mouth. The investigators will test these hypotheses by measuring pepsin levels from mouth fluid and comparing them with the number of GE reflux events the investigators find using the pH/impedance (MII (multichannel intraluminal impedance)) test. Since the investigators are interested in pepsin levels for all types of reflux - acid and non-acid -the investigators will study children whether or not they are on acid blocking medicines. The investigators will also look at pepsin levels in patients whose pH/MII is normal,

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2008-12
Est. Completion 2013-10

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT01091805

The ClinicalTrials.gov registry entry for NCT01091805 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01091805 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01091805 about?

NCT01091805 is a clinical study titled "Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux". The purpose of this research study is to see if GE reflux events are associated with increasing levels of pepsin in spit samples. Pepsin is a special protein called an "enzyme" that is made only in your stomach. It is not normally found in your throat. Pepsin breaks down food proteins that you eat t...

What is the current status of trial NCT01091805?

This trial is currently completed. The enrollment target is 143 participants. The study started on 2008-12. Estimated completion is 2013-10.

Who is sponsoring clinical trial NCT01091805?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.